Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fosamprenavir Expanded Access

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare
ClinicalTrials.gov Identifier:
NCT00240552
First received: October 14, 2005
Last updated: September 9, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given